Categories
Live Updates

M&A Update – May 4

– ARNC to be acquired by Apollo for $30.00 cash per share, 37.4% premium, $5.2 billion
– AMED to be acquired by OPCH for 3.0213x shares, 26.0% premium, $3.6 billion
– HEP received a non-binding merger proposal from DINO for 0.3714x shares, -2.2% discount
– GPP received a non-binding merger proposal from GPRE for 0.3913x shares, 0.0% premium
– JNCE / Concentra Biosciences deal closed
– FHN / TD deal terminated
– NUVA / GMED received second request from the FTC, closing pushed to Q3
– DSEY / Solenis (Platinum Equity) cleared China SAMR
– CVT / Blackstone filed DEFM14a, cleared HSR Apr 27, vote June 1, closing mid 2023
– LBC / WAFD votes